FDA feedback supports 505(b)(2) filing in H2 2026; No additional studies required beyond current planned 32-subject ...

The company recently hit significant roadblocks with its BTK inhibitor, but there are plenty of fish in the sea for the drug ...

Researchers have discovered that mimicking cold exposure or fasting can trigger an immune response in the body that slows ...

Your gut could be raising your risk of gynaecological cancer without you realising it. Leading gynaecologist discusses how ...

Novel small molecule inhibitors show promising efficacy in endometrial cancer, with ongoing trials expanding treatment ...

A new study links repeated binge drinking to persistent brain inflammation that reshapes mood, fear learning, and relapse ...

Detailed price information for Zentalis Pharmaceuticals Inc (ZNTL-Q) from The Globe and Mail including charting and trades.

With a White House drug pricing deal done and dusted and the threat of tariffs ameliorated, Sanofi is enjoying more clarity from the U.S. government now than the same time last year. But several ...

Nearly as soon as mental health and substance abuse organizations got notices that billions in federal grants were being ...

SONATA-HCM on track for enrollment completion in 2026 and topline data in 2027$10 million milestone payment triggered from licensing agreement ...

Director Srinivas Akkaraju of Alumis INC. (NASDAQ:ALMS) acquired 588,235 shares of common stock on January 9, 2026, at a price of $17.0, in one transaction. The total value of the purchase was $9,999, ...

First MIRACLE trial unblinding expected Q1 2026; Global trial now spans nine countries– Investigator-Initiated (IIT) funded pancreatic and ...